Please use this identifier to cite or link to this item:
|Title:||Bioprospecting a medicinal plant for therapeutics||Authors:||Ho, Malcolm Zheng Hao||Keywords:||Science::Biological sciences||Issue Date:||2020||Publisher:||Nanyang Technological University||Abstract:||Eleutherococcus trifoliatus, a valuable medicinal plant, has been used to treat injuries and diseases for centuries. Its orally active decoction may have the presence of cysteine-rich peptides (CRPs), a 2-6 kDa, functionally diverse and hyperdisulfide mini-proteins that have therapeutic relevance. This study reports the discovery, characterisation and therapeutic bioprospection of a CRP termed eleutherotide eT3670 extracted from E. trifoliatus. eT3670 consists of 35 amino acids and possesses an 8C-cysteine motif potentially forming six inter- cysteine loops via four intramolecular disulfide bonds that confer it resistance to thermal, acidic, enzymatic and serum-mediated degradation. Transcriptomic and bioinformatics analyses revealed that eT3670 is synthesised as a three-domain precursor, its disulfide connectivity as Cys I-IV, II-VI, III-VII, V-VIII, its inter-cysteine loops tolerance to amino acid variation and that it contains a variant LC3-interacting region motif related to selective autophagy. Cell-based assays showed that eT3670 is cytoprotective and a potential adaptogen that may induce autophagy to maintain cellular homeostasis, protecting cells from hypoxia stress-mediated damage and cell death. Together, the study bioprospects eT3670 as a potential candidate to be developed as a stable orally active drug for the treatment of autophagy-related diseases and as a grafting scaffold to enhance the stability of peptidyl therapeutics.||URI:||https://hdl.handle.net/10356/140947||Fulltext Permission:||embargo_restricted_20220513||Fulltext Availability:||With Fulltext|
|Appears in Collections:||SBS Student Reports (FYP/IA/PA/PI)|
Files in This Item:
|U1640518J_HO ZHENG HAO MALCOLM_BIOPROSPECTING A MEDICINAL PLANT FOR THERAPEUTICS (FINAL2).pdf|
|3.69 MB||Adobe PDF||Under embargo until May 13, 2022|
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.